[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20055921L - Heterocykliske metylsulfonderivater - Google Patents

Heterocykliske metylsulfonderivater

Info

Publication number
NO20055921L
NO20055921L NO20055921A NO20055921A NO20055921L NO 20055921 L NO20055921 L NO 20055921L NO 20055921 A NO20055921 A NO 20055921A NO 20055921 A NO20055921 A NO 20055921A NO 20055921 L NO20055921 L NO 20055921L
Authority
NO
Norway
Prior art keywords
substituent
heterocyclic
methylsulfone
derivatives
heterocyclic group
Prior art date
Application number
NO20055921A
Other languages
English (en)
Inventor
Hideki Kubota
Takanori Yasukouchi
Kayoko Motoki
Masanori Saito
Hitoshi Iimori
Satoru Miyauchi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20055921L publication Critical patent/NO20055921L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er tilveiebrakt en forbindelse som er i stand til inhibere produksjon eller sekresjon av P-amyloid-protein. Forbindelse representert ved den følgende formel (1): (hvor Rrepresenterer en heterocyklisk gruppe som kan ha en substituent, R2 representerer en cyklisk hydrokarbongruppe som kan ha en substituent eller en heterocyklisk gruppe som kan ha en substituent, Rrepresenterer en cyklisk hydrokarbongruppe som kan ha en substituent eller en heterocyklisk gruppe som kan ha en substituent, Rrepresenterer et hydrogenatom eller en C_alkylgnippe og X representerer -S-.-SO- eller -S0-); et N-oksyd eller S-oksyd derav; et salt derav; eller et solvat derav; og et medikament som inneholder hvilke som helst av disse.
NO20055921A 2003-06-30 2005-12-13 Heterocykliske metylsulfonderivater NO20055921L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003187796 2003-06-30
JP2004099151 2004-03-30
PCT/JP2004/009132 WO2005000798A1 (ja) 2003-06-30 2004-06-29 複素環メチルスルホン誘導体

Publications (1)

Publication Number Publication Date
NO20055921L true NO20055921L (no) 2006-01-24

Family

ID=33554493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055921A NO20055921L (no) 2003-06-30 2005-12-13 Heterocykliske metylsulfonderivater

Country Status (14)

Country Link
US (1) US7932271B2 (no)
EP (1) EP1640366A4 (no)
JP (1) JP4523914B2 (no)
KR (1) KR20060066057A (no)
AU (1) AU2004251987C1 (no)
CA (1) CA2526487A1 (no)
HK (1) HK1090362A1 (no)
IL (1) IL172139A0 (no)
MX (1) MXPA05013631A (no)
NO (1) NO20055921L (no)
PL (1) PL379466A1 (no)
RU (1) RU2336270C2 (no)
TW (1) TWI328005B (no)
WO (1) WO2005000798A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108591D0 (en) 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0120347D0 (en) 2001-08-21 2001-10-17 Merck Sharp & Dohme Therapeutic agents
JP4329905B2 (ja) * 2001-12-27 2009-09-09 第一三共株式会社 βアミロイド蛋白産生・分泌阻害剤
GB0223039D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
CA2526487A1 (en) 2003-06-30 2005-01-06 Daiichi Pharmaceutical Co., Ltd. Heterocyclic methyl sulfone derivative
ES2413705T3 (es) * 2005-04-08 2013-07-17 Daiichi Sankyo Company, Limited Derivado de piridilmetilsulfona
BRPI0713463A2 (pt) * 2006-06-22 2012-01-24 Atrazeneca Ab E Astex Therapeutics Ltd composto, formulação farmacêutica, uso de um composto, e, métodos para inibir a atividade de bace e para tratar ou prevenie uma patologia
JP2008115166A (ja) * 2006-10-10 2008-05-22 Daiichi Sankyo Co Ltd ピリジルフェニルメチルスルホン誘導体
CA2670418A1 (en) * 2006-11-24 2008-05-29 Ac Immune Sa N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimers's
TW200920362A (en) 2007-09-11 2009-05-16 Daiichi Sankyo Co Ltd Alkylsulfone derivatives
JP2010540629A (ja) * 2007-10-04 2010-12-24 メルク・シャープ・エンド・ドーム・コーポレイション カルシウムチャネル遮断薬としての置換アリールスルホン誘導体
EP2311823A1 (en) 2009-10-15 2011-04-20 AC Immune S.A. 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
UA103272C2 (uk) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
US9120752B2 (en) 2010-07-16 2015-09-01 Purdue Pharma, L.P. Pyridine compounds as sodium channel blockers
AU2013203824A1 (en) 2012-03-16 2013-10-03 Purdue Pharma L.P. Substituted pyridines and pryimidines as sodium channel blockers
EP2935257B1 (en) 2012-12-20 2018-02-07 Purdue Pharma LP Cyclic sulfonamides as sodium channel blockers
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
EP3436523B1 (en) * 2016-03-30 2022-07-06 Nikon Corporation Curable composition, cured product and optical member

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849423A (en) * 1971-03-22 1974-11-19 Lilly Co Eli 3-benzylpyridines
US4055652A (en) 1975-07-07 1977-10-25 Syntex (U.S.A.) Inc. 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof
ZA765075B (en) 1975-09-25 1977-08-31 American Cyanamid Co Hypolipemic compounds and method of treatment
US4116665A (en) * 1976-04-02 1978-09-26 Eli Lilly And Company Method of regulating the growth of aquatic weeds with pyridine derivatives
FR2375228A1 (fr) 1976-12-23 1978-07-21 Parcor Nouveaux benzothiophenes, leurs procedes de preparation et leur application notamment comme hypolipemiants et hypocholesterolemiants
DE2724684A1 (de) 1977-06-01 1978-12-14 Basf Ag Triazolsubstituierte schwefelverbindungen
DE2735314A1 (de) 1977-08-05 1979-02-22 Basf Ag Alpha-azolylsulfide und deren derivate
US4675316A (en) 1978-03-10 1987-06-23 Rohm And Haas Company Substituted azoylmethylarylsulfides and derivatives and pesticidal use thereof
ZA794030B (en) * 1978-08-08 1980-07-30 Sterling Drug Inc Aryl sulfinic acid derivatives of aliphatic,aromatic or heterocyclic compounds
US4379921A (en) 1980-08-21 1983-04-12 Sumitomo Chemical Company, Limited Production of triazolylvinyl ketones
FR2509725A1 (fr) 1981-07-15 1983-01-21 Choay Sa (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant
EP0117485A3 (de) 1983-02-28 1985-01-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyridin-, Pyrazin- und Pyrimidinderivate und deren Verwendung als fungizide Wirkstoffe
DE3406908A1 (de) 1984-02-25 1985-09-05 Hoechst Ag, 6230 Frankfurt Neue triazolylalkylderivate, verfahren zu ihrer herstellung sowie ihre verwendung als pflanzenbehandlungsmittel
JPS6239563A (ja) 1985-08-13 1987-02-20 Hokko Chem Ind Co Ltd β−ニトロフエネチル誘導体および農園芸用殺菌剤
US5359078A (en) 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
DE4215437A1 (de) 1992-05-11 1993-11-18 Paul Prof Dr Messinger Darstellung von Alkylacylaten mit ß-ständigen elektronenziehenden Resten im Alkylteil
JPH0625168A (ja) * 1992-07-10 1994-02-01 Nippon Bayeragrochem Kk 殺菌性ベンジルピリジン類
JPH0656780A (ja) * 1992-08-01 1994-03-01 Nippon Bayeragrochem Kk 殺菌性α−置換ベンジルピリジン類
DE19521355A1 (de) * 1995-06-12 1996-12-19 Hoechst Schering Agrevo Gmbh Sulfonamide, Verfahren zu deren Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
JPH0995444A (ja) 1995-10-02 1997-04-08 Teijin Ltd アミロイド蛋白凝集阻害剤
JP3868354B2 (ja) * 1997-02-27 2007-01-17 武田薬品工業株式会社 アミン誘導体、その製造法および剤
WO1998038156A1 (en) 1997-02-27 1998-09-03 Takeda Chemical Industries, Ltd. Amine compounds, their production and use as amyloid-beta production inhibitors
GB9902938D0 (en) * 1999-02-10 1999-03-31 Novartis Ag Organic compounds
EP1159263A1 (en) 1999-02-26 2001-12-05 Merck & Co., Inc. Novel sulfonamide compounds and uses thereof
ES2275657T3 (es) 2000-03-20 2007-06-16 MERCK SHARP & DOHME LTD. Derivados de bicicloalquilo puenteados sulfonamido sustituidos.
AU2001264872A1 (en) * 2000-06-05 2001-12-17 Ortho-Mcneil Pharmaceutical, Inc. Method for synthesis of substituted azole libraries
HUP0303857A3 (en) * 2000-12-13 2007-07-30 Wyeth Corp Heterocyclic sulifonamide inhibitors of beta amyloid production
GB0108592D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0108591D0 (en) 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
AR035260A1 (es) 2001-08-03 2004-05-05 Schering Corp Derivados de piperidina amino sustituidas, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de medicamentos como inhibidores de la gama secretasa, y para el tratamiento de la enfermedad de alzheimer
AU2002324582B9 (en) 2001-08-03 2006-02-16 Schering Corporation Novel gamma secretase inhibitors
DK1421062T3 (da) 2001-08-21 2008-02-18 Merck Sharp & Dohme Cyclohexylsulfoner
WO2003053912A1 (en) 2001-12-20 2003-07-03 Bristol-Myers Squibb Company α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
JP4329905B2 (ja) * 2001-12-27 2009-09-09 第一三共株式会社 βアミロイド蛋白産生・分泌阻害剤
DE10201392A1 (de) 2002-01-16 2003-07-31 Bayer Ag Phenylsulfoxide und-sulfone
TW200302717A (en) 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
GB0209991D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
GB0209997D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
US7041689B2 (en) 2002-05-01 2006-05-09 Merck Sharp & Dohme Ltd. Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
GB0209995D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
JP4530849B2 (ja) 2002-06-11 2010-08-25 ワイス・エルエルシー βアミロイド産生の置換フェニルスルホンアミド阻害剤
ES2315525T3 (es) * 2002-08-23 2009-04-01 Eli Lilly And Company Derivados de 2-(feniltiometil)-morfolina para uso como inhibidores selectivos de la recaptacion de norepinefrina.
GB0223040D0 (en) * 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0223038D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0223039D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0225475D0 (en) 2002-11-01 2002-12-11 Merck Sharp & Dohme Therapeutic agents
GB0225474D0 (en) 2002-11-01 2002-12-11 Merck Sharp & Dohme Therapeutic agents
CA2526487A1 (en) 2003-06-30 2005-01-06 Daiichi Pharmaceutical Co., Ltd. Heterocyclic methyl sulfone derivative

Also Published As

Publication number Publication date
MXPA05013631A (es) 2006-02-24
AU2004251987B8 (en) 2010-07-22
AU2004251987C1 (en) 2010-11-18
US20060241302A1 (en) 2006-10-26
IL172139A0 (en) 2006-04-10
HK1090362A1 (en) 2006-12-22
JPWO2005000798A1 (ja) 2006-08-03
AU2004251987A1 (en) 2005-01-06
PL379466A1 (pl) 2006-09-18
AU2004251987B2 (en) 2010-07-01
JP4523914B2 (ja) 2010-08-11
EP1640366A4 (en) 2009-05-13
EP1640366A1 (en) 2006-03-29
US7932271B2 (en) 2011-04-26
CA2526487A1 (en) 2005-01-06
TW200523251A (en) 2005-07-16
WO2005000798A1 (ja) 2005-01-06
RU2005141552A (ru) 2006-06-27
TWI328005B (en) 2010-08-01
RU2336270C2 (ru) 2008-10-20
KR20060066057A (ko) 2006-06-15

Similar Documents

Publication Publication Date Title
NO20055921L (no) Heterocykliske metylsulfonderivater
NO20081464L (no) 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer
NO20060219L (no) Forbindelser
NO20081551L (no) Heterocyklisk substituerte pyridinderivater og antisoppmidler inneholdende samme
NO20070457L (no) Pyrazolderivater
TW200633991A (en) Chemical compounds
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
MY145746A (en) Heterocyclic substituted pyridine derivatives and antifungal agent containing same
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
NO20065012L (no) Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse
WO2008078196A3 (en) Substituted heteroaryl pyridopyrimidone derivatives
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
NO20066015L (no) Fuserte heterosykliske forbindelser
NO20066055L (no) Pyridinderivater
NO20063446L (no) Tiazolderivater
UA95255C2 (en) Azole and thiazole derivatives and their use
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
WO2008136444A1 (ja) 縮合複素環誘導体
EA200971061A1 (ru) Пиримидоновые соединения гетероариламидов
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
NO20062202L (no) Amidometylsubstituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater, fremgangsmate og mellomprodukter for deres fremstilling, og legemidler som inneholder disse forbindelsene
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
NO20074346L (no) Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20082698L (no) Nye derivater, deres salter og antisoppmidler inneholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application